Highlights Novo Nordisk A/S Sao Paulo

Equities

Market Closed - Sao Paulo Other stock markets 16:11:00 2024-06-14 EDT			5-day change	1st Jan Change
95.34 ^BRL	+18.14%		-0.06%	+52.62%

06-14	Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy	RE
06-14	Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup	DJ

Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup	06-14	DJ
Novo Nordisk: study results for hemophilia A	06-14	CF
Employer coverage for weight-loss drugs rises sharply, survey finds	06-13	RE
IVivani Medical Gets FDA Clearance to Start Trial of GLP-1 Implant for Diabetes	06-13	DJ
Global markets live: Apple, Oracle, Amazon, Boeing, Tesla...	06-12
Health Care Down as Rally Pauses -- Health Care Roundup	06-11	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	06-11	MT
Novo Nordisk to Face Senate Panel Subpoena Vote Over Ozempic, Wegovy Prices	06-11	MT
Sector Update: Health Care Stocks Decline Tuesday Afternoon	06-11	MT
US Senate Committee to Subpoena Novo Nordisk Inc. President Over Prices of Diabetes, Obesity Drugs	06-11	MT
Senate Committee to Vote June 18 to Subpoena Novo Nordisk President Doug Langa	06-11	MT
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices	06-10	RE
Added health benefits of Wegovy, Zepbound could attract more men, doctors say	06-10	RE
Novo Nordisk braces for Ozempic rivals in China	06-06	RE
European equities gain on tech boost in run-up to ECB	06-06	RE
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic	06-05	RE
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China	06-05	RE
Health Care Climbs on Obesity-Drug Bets - Health Care Roundup	06-05	DJ
UK Stocks-Factors to watch on June 6	06-05	RE
UK Institute Makes Draft Recommendation for Eli Lilly's Weight-loss Drug With No Time Limit	06-05	MT